KOSDAQ-listed pharmaceutical firms' sales rise 12.4%

The 15 KOSDAQ-listed pharmaceutical manufacturing firms marketed combined sales of 347.2 billion won in the first nine months of this year, an increase of 12.4 percent due to brisk sales of generic or new drugs;

- Their operating profit stood at 61.0 billion won, down 9.4 percent, far lower than that of leading pharmaceutical firms whose fiscal year closed December 31^st;

- Their n...